← Back to Search

Behavioural Intervention

Study group for Tic Disorder

N/A

Recruiting

Led By Christine Conelea, PhD

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, post-treatment (week 8-10), follow up 1 (week 4-6 post-treatment) and follow up 2 (week 12-14) post-treatment)

Awards & highlights

Study Summary

This trial aims to study a treatment called CBIT for chronic tics, which are involuntary movements or sounds. CBIT focuses on helping patients control their tics by learning alternative actions. The study will

Who is the study for?

This trial is for young people aged 12-21 with chronic motor and/or vocal tics, which have lasted at least a year without a break of more than three months. Participants should have moderate tic severity as measured by the Yale scale, an IQ over 70, and must understand English well.Check my eligibility

What is being tested?

The study tests CBIT (Comprehensive Behavioral Intervention for Tics), focusing on increasing control over tics through competing response training. The treatment's effectiveness will be monitored across eight sessions using video recordings and assessments of behavior and overall functioning.See study design

What are the potential side effects?

CBIT is a non-medical therapy focused on behavior modification rather than medication; therefore, it typically does not involve drug-related side effects. However, participants may experience fatigue or frustration during the learning process.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, post-treatment (week 8-10), follow up 1 (week 4-6 post-treatment) and follow up 2 (week 12-14) post-treatment)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, post-treatment (week 8-10), follow up 1 (week 4-6 post-treatment) and follow up 2 (week 12-14) post-treatment)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-treatment (week 8-10), follow up 1 (week 4-6 post-treatment) and follow up 2 (week 12-14) post-treatment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Ask Suicide-Screening Questions (ASQ)

Behavior Rating Inventory of Executive Function

Caregiver Strain Questionnaire

+6 more

Secondary outcome measures

Premonitory Urge for Tics Scale

Stop signal task

Tic Suppression Task

Trial Design

1Treatment groups

Experimental Treatment

Group I: Study groupExperimental Treatment1 Intervention

Youth ages 12-21 years with chronic tics will complete a course of 10 outpatient, weekly CBIT sessions with pre-, post-, 1-month and 3-month follow up assessments.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,381 Previous Clinical Trials

1,588,945 Total Patients Enrolled

Christine Conelea, PhDPrincipal InvestigatorUniversity of Minnesota

3 Previous Clinical Trials

146 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age threshold for participants in this research, specifically regarding individuals over 35 years of age?

"Individuals aged between 12 and 21 are eligible for participation in this clinical trial based on the specified age requirements."

Answered by AI

Are individuals still eligible to apply for participation in this ongoing trial?

"As per the details on clinicaltrials.gov, this current research study is actively seeking individuals to enroll. It was first listed on 3/1/2024 and last revised on 3/28/2024."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Modeling Tic Change During Behavior Therapy for Tics

2024. "Modeling Tic Change During Behavior Therapy for Tics". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06270251.

All > Paid Studies Minneapolis